{"url_path":"/sec/pdsb/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1472091/0001140361-26-032142-index.html","accession_number":"0001140361-26-032142","cik":"0001472091","ticker":"PDSB","issuer_name":"PDS Biotechnology Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1472091/0001140361-26-032142-index.html","primary_entity_key":"0001472091","primary_entity_name":"PDS Biotechnology Corp"},"word_count":83,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit\n\nNumber\n\n \n\nDescription\n\n \n\n \n\n \n\n[99.1](ef20079931_ex99-1.htm)\n\n \n\nShareholder Letter dated August 11, 2026\n\n \n\n \n\n \n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSignature\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its\nbehalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nPDS BIOTECHNOLOGY CORPORATION\n\n \n\n \n\n \n\nDate: August 11, 2026\n\nBy: /s/ Frank Bedu-Addo, Ph.D.\n\n \n\n \n\nName: Frank Bedu-Addo, Ph.D.\n\n \n\n \n\nTitle: President and Chief Executive Officer"}